海泰新光跌0.67%，成交额3834.90万元，后市是否有机会？

Core Viewpoint - The company, Qindao Haitai New Light Technology Co., Ltd., is focused on integrating optical technology with cutting-edge applications in the medical device industry, particularly in high-performance endoscope products. It has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, indicating its strong market position and technological capabilities [2][7]. Company Overview - Qindao Haitai New Light was established on June 11, 2003, and went public on February 26, 2021. Its main business includes the research, development, production, and sales of medical endoscope devices and optical products. The revenue composition is as follows: medical endoscope devices 64.86%, optical products 21.63%, maintenance services 13.09%, and leasing 0.42% [7]. - As of September 30, 2025, the company reported a revenue of 448 million yuan, representing a year-on-year growth of 40.47%, and a net profit attributable to shareholders of 136 million yuan, also showing a growth of 40.03% [7]. Market Position and Financials - The company has a significant overseas revenue share of 69.12%, benefiting from the depreciation of the Renminbi [3]. - The total market capitalization of the company is 5.828 billion yuan, with a trading volume of 38.349 million yuan and a turnover rate of 0.66% on November 7 [1]. Shareholder Information - As of September 30, 2025, the number of shareholders is 5,188, a decrease of 1.84% from the previous period. The average circulating shares per person increased by 1.87% to 23,106 shares [7]. - The company has distributed a total of 277 million yuan in dividends since its A-share listing, with 207 million yuan distributed over the past three years [8]. Technical Analysis - The average trading cost of the stock is 46.47 yuan, with the current price approaching a support level of 48.40 yuan. A breach of this support level may indicate a potential downward trend [6].